U100 OSMOLALITY, URINE : SERUM RATIO
H012 OSMOTIC FRAGILITY TEST; RBC FRAGILITY TEST
R108 OSTEOCALCIN; BONE Gla PROTEIN (BGP)
B165 P1NP (PROCOLLAGEN TYPE 1 AMINO TERMINAL PROPEPTIDE ) TOTAL
B165A P1NP (PROCOLLAGEN TYPE 1 AMINO TERMINAL PROPEPTIDE), TOTAL
P093 PACKED CELL VOLUME (PCV), BODY FLUIDS
H002 PACKED CELL VOLUME (PCV); HEMATOCRIT
OS175 PAN FUNGAL DETECTION AND IDENTIFICTION, PCR
B152 PAPP-A (PREGNANCY ASSOCIATED PLASMA PROTEIN-A)
S087 PARIETAL CELL ANTIBODY, IFA IN DILUTIONS
Z496 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH), CONFIRMATORY TEST
H014 PARTIAL THROMBOPLASTIN TIME, ACTIVATED; PTT; APTT
Z185 PARVOVIRUS B19 ANTIBODIES PANEL, IgG & IgM
N124 PARVOVIRUS B19, QUALITATIVE PCR
H224 PAS (PERIODIC ACID SCHIFF) STAIN, BLOOD / BONE MARROW
Z838 PCOD (POLYCYSTIC OVARIAN DISEASE) COMPREHENSIVE PANEL
B170 PCOD (POLYCYSTIC OVARIAN DISEASE) PANEL
Z516 PERITONEAL DIALYSIS ADEQUACY TEST
Z517 PERITONEAL EQUILIBRIUM & ADEQUACY TEST
Z515 PERITONEAL EQUILIBRIUM TEST (PET)
K016 PHENCYCLIDINE (PCP), SCREEN, URINE
Z167 PHOSPHATIDYLSERINE ANTIBODIES PANEL, IgG & IgM
S120 PHOSPHATIDYLSERINE ANTIBODY, IgG
S121 PHOSPHATIDYLSERINE ANTIBODY, IgM
S255 PHOSPHOLIPASE A2 RECEPTOR ANTIBODY (PLA2R), QUANTITATIVE
S240 PHOSPHOLIPASE A2 RECEPTOR ANTIBODY (PLA2R)
Z287 PHOSPHOLIPID ANTIBODIES PANEL, IgG & IgM
Z854 PHOSPHOLIPID SYNDROME PANEL WITH BETA 2 GLYCOPROTEIN 1, IHR